PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 14 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,298,019 | +20.3% | 3,368,000 | -2.3% | 0.09% | +18.9% |
| Q1 2023 | $2,740,365 | -9.7% | 3,447,000 | 0.0% | 0.07% | -8.6% |
| Q4 2022 | $3,033,360 | +7.4% | 3,447,000 | +8.0% | 0.08% | +1.2% |
| Q3 2022 | $2,824,000 | +3.5% | 3,192,000 | 0.0% | 0.08% | +8.1% |
| Q2 2022 | $2,728,000 | -3.1% | 3,192,000 | 0.0% | 0.07% | +13.8% |
| Q1 2022 | $2,816,000 | -3.2% | 3,192,000 | 0.0% | 0.06% | +10.2% |
| Q4 2021 | $2,909,000 | +2.8% | 3,192,000 | 0.0% | 0.06% | -4.8% |
| Q3 2021 | $2,829,000 | -10.3% | 3,192,000 | -5.9% | 0.06% | -12.7% |
| Q2 2021 | $3,154,000 | +1.6% | 3,392,000 | -1.6% | 0.07% | -2.7% |
| Q1 2021 | $3,103,000 | +4.5% | 3,448,000 | 0.0% | 0.07% | -3.9% |
| Q4 2020 | $2,970,000 | -7.2% | 3,448,000 | -10.7% | 0.08% | -20.0% |
| Q3 2020 | $3,202,000 | +0.2% | 3,859,000 | -2.3% | 0.10% | -6.9% |
| Q2 2020 | $3,197,000 | +20.5% | 3,950,000 | +5.3% | 0.10% | +8.5% |
| Q1 2020 | $2,653,000 | -1.2% | 3,750,000 | 0.0% | 0.09% | +23.7% |
| Q4 2019 | $2,684,000 | -1.0% | 3,750,000 | 0.0% | 0.08% | -8.4% |
| Q3 2019 | $2,712,000 | +2.6% | 3,750,000 | 0.0% | 0.08% | +1.2% |
| Q2 2019 | $2,643,000 | – | 3,750,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |